Agenda
- Introduction to In Vitro Pharmacology (IVP) and problematics faced during submission of IVP data for an IND application
- How to pave the way to the FAIRification of IVP data? Two key steps:
- Standardised data structure for submission of results – IVP module/GSRS
- Repository of safety and secondary in vitro pharmacology assays: using a single, centralised protocol repository with an integrated ontology and providing a unique Identifier for each assay
- Q&A session
Speakers
- Kevin Snyder (FDA)
- Larry Callahan (FDA)
- Jane Lomax (Scibite)
- Chris Butler (Abbvie)
Fill in the form below to view a recording of the event